1027-69-6

Usage

Uses

1. Used in Pharmaceutical Applications:
1-(4-Methoxyphenyl)-1,3,8-triazaspiro[4.5]decan-4-one is used as a potential pharmaceutical compound due to its unique spiro ring system and triazaspirodecane core. Its complex molecular structure may offer interesting biological activities, warranting further research into its possible therapeutic uses.
2. Used in Medical Applications:
In the medical field, 1-(4-Methoxyphenyl)-1,3,8-triazaspiro[4.5]decan-4-one may be utilized as a starting point for developing new drugs or therapies. Its specific properties and potential interactions with biological systems could lead to novel treatments for various conditions.
3. Used in Chemical Research:
As a complex spiro compound, 1-(4-Methoxyphenyl)-1,3,8-triazaspiro[4.5]decan-4-one can be employed in chemical research to study the effects of its unique structure on various chemical and biological processes. This may contribute to a better understanding of spiro compounds and their potential applications in different industries.
4. Used in Material Science:
1-(4-Methoxyphenyl)-1,3,8-triazaspiro[4.5]decan-4-one's unique structure and properties may also find applications in material science, where it could be used to develop new materials with specific characteristics or to enhance the properties of existing materials.

Downstream Products

• 97861-01-3 8-{3-[Bis-(4-fluoro-phenyl)-amino]-propyl}-1-(4-methoxy-phenyl)-1,3,8-triaza-spiro[4.5]decan-4-one 
• 1352949-35-9 3-((1-(4-methoxyphenyl)-4-oxo-8-(3-(2-oxobenzo[d]thiazol-3(2H)-yl)propyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoic acid 
• 1352948-97-0 methyl 3-((1-(4-methoxyphenyl)-4-oxo-8-(3-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)propyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoate 
• 1352949-36-0 methyl 3-((1-(4-methoxyphenyl)-4-oxo-8-(3-(2-oxobenzo[d]thiazol-3(2H)-yl)propyl)-1,3,8-triazaspiro[4.5]decan-3-yl)methyl)benzoate 
• 1352948-98-1 tert-butyl 3-(3-(methoxycarbonyl)benzyl)-1-(4-methoxyphenyl)-4-oxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate 
• 1352949-00-8 tert-butyl-1-(4-methoxyphenyl)-4-oxo-1,3,8-triazraspiro[4.5]decane-8-carboxylate 
• 851338-67-5 rac-1-(4-methoxy-phenyl)-8-(2-oxo-cyclohexyl)-1,3,8-triaza-spiro[4.5]decan-4-one 

Relevant academic research and scientific papers

TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS

The invention relates to compounds of the general formula (I), wherein A-A is -CH2-CH2-, -CH2-CH2-CH2-, -CH2-0- or -0-CH2-; x is hydrogen or hydroxy; R1 is aryl or heteroaryl, unsubstituted or substituted by one or more substituents, selected from the group consisting of lower alkyl, lower alkoxy, halogen or trifluoromethyl; R2 is aryl or heteroaryl, unsubstituted or substituted by one or more substituents, selected from the group consisting of lower alkyl, lower alkoxy, halogen or trifluoromethyl, or is lower alkyl, -(CH2)n--cycloalkyl, -(CH2)n-CF3, -(CH2)p-0-lower alkyl, -(CH2)1,2-phenyl, optionally substituted by halogen, lower alkyl, lower alkoxy or trifluoromethyl, or is -(CH2)p-NRR", wherein W and R" form together with the N-atom a heterocyclic ring, selected from the group consisting of piperidine, morpholine, thiomorpholine or 1, I-dioxo thiomorpholine; R3, R4 are independently from each other hydrogen, lower alkyl, phenyl or benzyl; R5 is hydrogen, lower alkyl or benzyl; R6 is hydrogen or lower alkyl; n is 0, 1 or 2; and p is 2 or 3; and to pharmaceutically acceptable acid addition salts thereof for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.